Inventor · disambiguated record
Lance Ford
Also filed as: FORD LANCE · FORD LANCE P · FORD LANCE PHILIP
15 granted patents·31 pending applications·338 citations·filing 1999–2024
95Inventor score
Top patents by PatentIndex Score
46 records- 0198US9506061B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2015·Granted Nov 29, 2016·165 cites·7 claims
- 0296US8173611B2Methods and compositions involving miRNA and miRNA inhibitor moleculesBROWN DAVID·Filed 2005·Granted May 8, 2012·27 cites·27 claims
- 0396US7960359B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2007·Granted Jun 14, 2011·37 cites·17 claims
- 0495US8058250B2Methods and compositions involving miRNA and miRNA inhibitor moleculesBROWN DAVID·Filed 2007·Granted Nov 15, 2011·20 cites·31 claims
- 0594US8563708B2Methods and compositions involving miRNA and miRNA inhibitor moleculesBROWN DAVID·Filed 2007·Granted Oct 22, 2013·15 cites·9 claims
- 0692US8946177B2Methods and compositions involving miRNA and miRNA inhibitor moleculesBROWN DAVID·Filed 2011·Granted Feb 3, 2015·10 cites·16 claims
- 0789US8524680B2High potency siRNAS for reducing the expression of target genesBROWN DAVID·Filed 2009·Granted Sep 3, 2013·12 cites·18 claims
- 0888US8058255B2Methods and compositions concerning siRNA's as mediators of RNA interferenceFORD LANCE P·Filed 2009·Granted Nov 15, 2011·15 cites·19 claims
- 0985US9447414B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2015·Granted Sep 20, 2016·2 cites·3 claims
- 1085US9051571B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2014·Granted Jun 9, 2015·3 cites·28 claims
- 1185US8765709B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2013·Granted Jul 1, 2014·3 cites·22 claims
- 1283US9382537B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2014·Granted Jul 5, 2016·2 cites·10 claims
- 1383US9068219B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2014·Granted Jun 30, 2015·2 cites·33 claims
- 1483US8900627B2Compositions for the in vivo delivery of RNAi agentsFORD LANCE·Filed 2009·Granted Dec 2, 2014·6 cites·29 claims
- 1567US2017037404A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2016·Application pending·0 cites
- 1667US2013303591A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2013·Application pending·0 cites
- 1767US2024418721A1Methods and Kits for Ribonuclease DetectionFORD LANCE PHILIP·Filed 2024·Application pending·0 cites
- 1866US6627398B1System for reproducing and modulating stability and turnover of RNA moleculesUNIV NEW JERSEY MED·Filed 1999·Granted Sep 30, 2003·19 cites·45 claims
- 1966US2013143945A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2013·Application pending·0 cites
- 2065US2014179762A1METHODS AND COMPOSITIONS REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNASAPPLIED BIOSYSTEMS LLC·Filed 2013·Application pending·0 cites
- 2164US2015361431A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2264US2014295543A1Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interferenceAPPLIED BIOSYSTEMS LLC·Filed 2013·Application pending·0 cites
- 2363US2015342981A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2463US2015284720A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2563US2013231266A1METHODS AND COMPOSITIONS REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNASAPPLIED BIOSYSTEMS LLC·Filed 2013·Application pending·0 cites
- 2663US2015344883A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2763US2015299705A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2863US2011313025A1Methods and compositions involving mirna and mirna inhibitor moleculesBROWN DAVID·Filed 2011·Application pending·0 cites
- 2963US2015284719A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 3063US2015275213A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 3162US2011151558A1METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNASLIFE TECHNOLOGIES CORP·Filed 2011·Application pending·0 cites
- 3262US2010184039A1Methods and compositions relating to labeled rna molecules that reduce gene expressionLIFE TECHNOLOGIES CORP·Filed 2009·Application pending·0 cites
- 3361US2004033602A1Methods and compositions relating to polypeptides with RNase III domains that mediate RNA interferenceAMBION INC·Filed 2003·Application pending·0 cites
- 3461US2013230920A1Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interferenceAPPLIED BIOSYSTEMS LLC·Filed 2013·Application pending·0 cites
- 3561US2012122217A1METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNASBROWN DAVID·Filed 2012·Application pending·0 cites
- 3660US2006142228A1Methods and compositions concerning siRNA's as mediators of RNA interferenceAMBION INC·Filed 2004·Application pending·0 cites
- 3760US2004029275A1Methods and compositions for reducing target gene expression using cocktails of siRNAs or constructs expressing siRNAsFiled 2002·Application pending·0 cites
- 3858US2014099715A1High potency sirnas for reducing the expression of target genesAPPLIED BIOSYSTEMS LLC·Filed 2013·Application pending·0 cites
- 3955US2003166282A1High potency siRNAS for reducing the expression of target genesFiled 2003·Application pending·0 cites
- 4055US2010075423A1Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interferenceLIFE TECHNOLOGIES CORP·Filed 2009·Application pending·0 cites
- 4155US2012028312A1Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interferenceFORD LANCE P·Filed 2011·Application pending·0 cites
- 4250US2004248094A1Methods and compositions relating to labeled RNA molecules that reduce gene expressionFiled 2002·Application pending·0 cites
- 4350US2003232360A1System for reproducing and modulating stability and turnover of RNA moleculesFiled 2003·Application pending·0 cites
- 4450US2011257375A1Increasing efficiency of nucleic acid delivery in vivo using targeting conjugatesFORD LANCE P·Filed 2009·Application pending·0 cites
- 4544US2013052647A1Methods for fractionating and processing microparticles from biological samples and using them for biomarker discoveryGOLDRICK MARIANNA·Filed 2011·Application pending·0 cites
- 4638US2011269137A1Rapid and efficient assay to assess the sequence and size of 3' ends of polynucleotidesFORD LANCE P·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lance Ford files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →